OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Overcoming resistance to immune checkpoint inhibitors in hepatocellular carcinoma: Challenges and opportunities
Qingqing Xie, Pengfei Zhang, Yuanyuan Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 19
Qingqing Xie, Pengfei Zhang, Yuanyuan Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 19
Showing 19 citing articles:
Augmenting Cancer Therapy with a Supramolecular Immunogenic Cell Death Inducer: A Lysosome-Targeted NIR-Light-Activated Ruthenium(II) Metallacycle
Le Tu, Chonglu Li, Qihang Ding, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 13, pp. 8991-9003
Closed Access | Times Cited: 44
Le Tu, Chonglu Li, Qihang Ding, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 13, pp. 8991-9003
Closed Access | Times Cited: 44
Immunotherapy and liver transplantation for hepatocellular carcinoma: Current and future challenges
Theodoros Pettas, Sofia Lachanoudi, Filippos F. Karageorgos, et al.
World Journal of Transplantation (2025) Vol. 15, Iss. 2
Closed Access | Times Cited: 1
Theodoros Pettas, Sofia Lachanoudi, Filippos F. Karageorgos, et al.
World Journal of Transplantation (2025) Vol. 15, Iss. 2
Closed Access | Times Cited: 1
Advances in Immunotherapy for Hepatocellular Carcinoma (HCC)
Fuat Bicer, Catrina Kure, Anil A. Ozluk, et al.
Current Oncology (2023) Vol. 30, Iss. 11, pp. 9789-9812
Open Access | Times Cited: 16
Fuat Bicer, Catrina Kure, Anil A. Ozluk, et al.
Current Oncology (2023) Vol. 30, Iss. 11, pp. 9789-9812
Open Access | Times Cited: 16
Navigating the Immune Maze: Pioneering Strategies for Unshackling Cancer Immunotherapy Resistance
Liqin Yao, Qingqing Wang, Wenxue Ma
Cancers (2023) Vol. 15, Iss. 24, pp. 5857-5857
Open Access | Times Cited: 13
Liqin Yao, Qingqing Wang, Wenxue Ma
Cancers (2023) Vol. 15, Iss. 24, pp. 5857-5857
Open Access | Times Cited: 13
Revisiting immune checkpoint inhibitors: new strategies to enhance efficacy and reduce toxicity
Dianying Zhang, Jingjing Zhao, Yujing Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Dianying Zhang, Jingjing Zhao, Yujing Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Assessing the Causal Effect of Circulating Protein‐To‐Protein Ratio on the Risk of Morbidity of Hepatocellular Carcinoma
Qiuyuan Yue, Xiaoxia Li, Xiang Wan, et al.
Cancer Medicine (2025) Vol. 14, Iss. 1
Open Access
Qiuyuan Yue, Xiaoxia Li, Xiang Wan, et al.
Cancer Medicine (2025) Vol. 14, Iss. 1
Open Access
LINC00870 promotes imatinib resistance in gastrointestinal stromal tumor via inhibiting PIGR glycosylation modifications
Yuan Li, Zhiqiang Dai, Zewei Cheng, et al.
Heliyon (2025) Vol. 11, Iss. 3, pp. e41934-e41934
Open Access
Yuan Li, Zhiqiang Dai, Zewei Cheng, et al.
Heliyon (2025) Vol. 11, Iss. 3, pp. e41934-e41934
Open Access
Advancements in immunotherapy for hepatocellular carcinoma
S. Ascari, Rusi Chen, Caterina Vivaldi, et al.
Expert Review of Anticancer Therapy (2025) Vol. 25, Iss. 2, pp. 151-165
Closed Access
S. Ascari, Rusi Chen, Caterina Vivaldi, et al.
Expert Review of Anticancer Therapy (2025) Vol. 25, Iss. 2, pp. 151-165
Closed Access
An immune sandwich electrochemical biosensor based on triple-modified zirconium derivatives for detection of CD146 in serum
Die Chen, Yutao He, Ya Wang, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 239, pp. 113902-113902
Closed Access | Times Cited: 3
Die Chen, Yutao He, Ya Wang, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 239, pp. 113902-113902
Closed Access | Times Cited: 3
Immune-Based Combination Therapies for Advanced Hepatocellular Carcinoma
Riccardo Carloni, S Sabbioni, Alessandro Rizzo, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 1445-1463
Open Access | Times Cited: 7
Riccardo Carloni, S Sabbioni, Alessandro Rizzo, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 1445-1463
Open Access | Times Cited: 7
Interplay among extracellular vesicles, cancer stemness and immune regulation in driving hepatocellular carcinoma progression
Yu‐Man Tsui, Lü Tian, Jingyi Lu, et al.
Cancer Letters (2024) Vol. 597, pp. 217084-217084
Open Access | Times Cited: 2
Yu‐Man Tsui, Lü Tian, Jingyi Lu, et al.
Cancer Letters (2024) Vol. 597, pp. 217084-217084
Open Access | Times Cited: 2
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma
Giulia Francesca Manfredi, Ciro Celsa, Chloe John, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 1955-1971
Open Access | Times Cited: 6
Giulia Francesca Manfredi, Ciro Celsa, Chloe John, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 1955-1971
Open Access | Times Cited: 6
Unraveling the Complexities of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
Xinpu Han, Qianhui Sun, Manman Xu, et al.
Seminars in Liver Disease (2023) Vol. 43, Iss. 04, pp. 383-401
Closed Access | Times Cited: 3
Xinpu Han, Qianhui Sun, Manman Xu, et al.
Seminars in Liver Disease (2023) Vol. 43, Iss. 04, pp. 383-401
Closed Access | Times Cited: 3
Current landscape of exosomes in tuberculosis development, diagnosis, and treatment applications
Xue‐Zhi Sun, Wei Li, Li Zhao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Xue‐Zhi Sun, Wei Li, Li Zhao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Unveiling intricating roles and mechanisms of ferroptosis in melanoma
Tao Rui, Yichuan Li, Song Gong, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1880, Iss. 1, pp. 189234-189234
Closed Access
Tao Rui, Yichuan Li, Song Gong, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1880, Iss. 1, pp. 189234-189234
Closed Access
LAG3 immune inhibitors: a novel strategy for melanoma treatment
Renzheng Wu, Mingtang Zeng, Yuchen Zhang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Renzheng Wu, Mingtang Zeng, Yuchen Zhang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
The impact of ferroptosis and ferroptosis-related non-coding RNAs on breast cancer progression
Wenhui Liu, Chenjun Jiang, Yun Ma, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access
Wenhui Liu, Chenjun Jiang, Yun Ma, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access
Navigating the Immune Maze: Pioneering Strategies for Un-shackling Cancer Immunotherapy Resistance
Liqin Yao, Qingqing Wang, Wenxue Ma
(2023)
Open Access | Times Cited: 1
Liqin Yao, Qingqing Wang, Wenxue Ma
(2023)
Open Access | Times Cited: 1
A New Frontier of Neoadjuvant Immunotherapy for Hepatocellular Carcinoma
秋洋 任
Advances in Clinical Medicine (2023) Vol. 13, Iss. 03, pp. 4382-4388
Closed Access
秋洋 任
Advances in Clinical Medicine (2023) Vol. 13, Iss. 03, pp. 4382-4388
Closed Access
